Tamarly Intelligence
Company · RDY (New York Stock Exchange)

DR Reddys Laboratories Ltd

Pharmaceutical Preparations

Key figures
Revenue, 2025
$3.81B
Industry
Pharmaceutical Preparations (SIC 2834)
Institutional holders
238 at 30 Jun 2026 (249 the quarter before)
SEC number
1135951

Source: SEC EDGAR filings and company facts, SEC Form 13F; checked 27 Oct 2026

About

DR Reddys Laboratories Ltd is an Indian integrated pharmaceutical company in pharmaceutical industry, headquartered in Hyderabad, founded in 1984.

Source: Wikidata

Latest filings
26 Oct 2026
6-K FORM 6-K
26 Oct 2026
6-K FORM 6-K
23 Oct 2026
6-K FORM 6-K
23 Oct 2026
6-K FORM 6-K
23 Oct 2026
6-K FORM 6-K

Source: SEC EDGAR

With a free account

A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.

Start freeSign in

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.

DR Reddys Laboratories Ltd: Revenue $3.81B (2025), filings, holders and country risk | Tamarly